112 related articles for article (PubMed ID: 17548156)
1. High dopamine turnover in the brains of Sandy mice.
Murotani T; Ishizuka T; Hattori S; Hashimoto R; Matsuzaki S; Yamatodani A
Neurosci Lett; 2007 Jun; 421(1):47-51. PubMed ID: 17548156
[TBL] [Abstract][Full Text] [Related]
2. Behavioral abnormalities and dopamine reductions in sdy mutant mice with a deletion in Dtnbp1, a susceptibility gene for schizophrenia.
Hattori S; Murotani T; Matsuzaki S; Ishizuka T; Kumamoto N; Takeda M; Tohyama M; Yamatodani A; Kunugi H; Hashimoto R
Biochem Biophys Res Commun; 2008 Aug; 373(2):298-302. PubMed ID: 18555792
[TBL] [Abstract][Full Text] [Related]
3. Dysfunction of dopamine release in the prefrontal cortex of dysbindin deficient sandy mice: an in vivo microdialysis study.
Nagai T; Kitahara Y; Shiraki A; Hikita T; Taya S; Kaibuchi K; Yamada K
Neurosci Lett; 2010 Feb; 470(2):134-8. PubMed ID: 20045719
[TBL] [Abstract][Full Text] [Related]
4. Behavioral characterization of dysbindin-1 deficient sandy mice.
Bhardwaj SK; Baharnoori M; Sharif-Askari B; Kamath A; Williams S; Srivastava LK
Behav Brain Res; 2009 Feb; 197(2):435-41. PubMed ID: 18984010
[TBL] [Abstract][Full Text] [Related]
5. The sandy (sdy) mouse: a dysbindin-1 mutant relevant to schizophrenia research.
Talbot K
Prog Brain Res; 2009; 179():87-94. PubMed ID: 20302821
[TBL] [Abstract][Full Text] [Related]
6. Neurochemical investigations of dopamine neuronal systems in iron-regulatory protein 2 (IRP-2) knockout mice.
Salvatore MF; Fisher B; Surgener SP; Gerhardt GA; Rouault T
Brain Res Mol Brain Res; 2005 Oct; 139(2):341-7. PubMed ID: 16051392
[TBL] [Abstract][Full Text] [Related]
7. Dysbindin deficiency in sandy mice causes reduction of snapin and displays behaviors related to schizophrenia.
Feng YQ; Zhou ZY; He X; Wang H; Guo XL; Hao CJ; Guo Y; Zhen XC; Li W
Schizophr Res; 2008 Dec; 106(2-3):218-28. PubMed ID: 18774265
[TBL] [Abstract][Full Text] [Related]
8. Sex differences in catechol contents in the olfactory bulb of control and unilaterally deprived rats.
Gómez C; Briñón JG; Valero J; Recio JS; Murias AR; Curto GG; Orio L; Colado MI; Alonso JR
Eur J Neurosci; 2007 Mar; 25(5):1517-28. PubMed ID: 17425578
[TBL] [Abstract][Full Text] [Related]
9. Impaired long-term memory retention and working memory in sdy mutant mice with a deletion in Dtnbp1, a susceptibility gene for schizophrenia.
Takao K; Toyama K; Nakanishi K; Hattori S; Takamura H; Takeda M; Miyakawa T; Hashimoto R
Mol Brain; 2008 Oct; 1():11. PubMed ID: 18945333
[TBL] [Abstract][Full Text] [Related]
10. Episodic-like and procedural memory impairments in histamine H1 Receptor knockout mice coincide with changes in acetylcholine esterase activity in the hippocampus and dopamine turnover in the cerebellum.
Dere E; Zlomuzica A; Viggiano D; Ruocco LA; Watanabe T; Sadile AG; Huston JP; De Souza-Silva MA
Neuroscience; 2008 Dec; 157(3):532-41. PubMed ID: 18926883
[TBL] [Abstract][Full Text] [Related]
11. Mice with dopaminergic neuron-specific deletion of DTNBP-1 gene show blunted nucleus accumbens dopamine release and associated behaviors.
Bhardwaj SK; Cui Q; Moquin L; Gratton A; Giros B; Srivastava LK
Neuropharmacology; 2021 Feb; 184():108440. PubMed ID: 33340529
[TBL] [Abstract][Full Text] [Related]
12. [Risk genes for schizophrenia and neuronal plasticity: molecular target for antipsychotic discovery].
Hashimoto R; Yasuda Y; Ohi K; Fukumoto M; Yamamori H; Takeda M
Nihon Shinkei Seishin Yakurigaku Zasshi; 2010 Jun; 30(3):103-7. PubMed ID: 20666140
[TBL] [Abstract][Full Text] [Related]
13. Modification of inherent and drug-induced dopaminergic activity after exposure to benzo(alpha)pyrene.
Konstandi M; Harkitis P; Thermos K; Ogren SO; Johnson EO; Tzimas P; Marselos M
Neurotoxicology; 2007 Jul; 28(4):860-7. PubMed ID: 17570529
[TBL] [Abstract][Full Text] [Related]
14. Hyperactivation of midbrain dopaminergic system in schizophrenia could be attributed to the down-regulation of dysbindin.
Kumamoto N; Matsuzaki S; Inoue K; Hattori T; Shimizu S; Hashimoto R; Yamatodani A; Katayama T; Tohyama M
Biochem Biophys Res Commun; 2006 Jun; 345(2):904-9. PubMed ID: 16701550
[TBL] [Abstract][Full Text] [Related]
15. Ketogenic diet protects dopaminergic neurons against 6-OHDA neurotoxicity via up-regulating glutathione in a rat model of Parkinson's disease.
Cheng B; Yang X; An L; Gao B; Liu X; Liu S
Brain Res; 2009 Aug; 1286():25-31. PubMed ID: 19559687
[TBL] [Abstract][Full Text] [Related]
16. Neuroprotective effects of genistein on dopaminergic neurons in the mice model of Parkinson's disease.
Liu LX; Chen WF; Xie JX; Wong MS
Neurosci Res; 2008 Feb; 60(2):156-61. PubMed ID: 18054104
[TBL] [Abstract][Full Text] [Related]
17. Sporadic midbrain dopamine neuron abnormalities in laboratory mice.
Prasad K; Richfield EK
Neurobiol Dis; 2008 Nov; 32(2):262-72. PubMed ID: 18687402
[TBL] [Abstract][Full Text] [Related]
18. Dopaminergic and serotoninergic deficiencies in young adult rats prenatally exposed to the bacterial lipopolysaccharide.
Wang S; Yan JY; Lo YK; Carvey PM; Ling Z
Brain Res; 2009 Apr; 1265():196-204. PubMed ID: 19236855
[TBL] [Abstract][Full Text] [Related]
19. Comparative immunohistochemical study of the dopaminergic systems in two inbred mouse strains (C57BL/6J and DBA/2J).
D'Este L; Casini A; Puglisi-Allegra S; Cabib S; Renda TG
J Chem Neuroanat; 2007 Mar; 33(2):67-74. PubMed ID: 17276033
[TBL] [Abstract][Full Text] [Related]
20. Paraquat induces alternation of the dopamine catabolic pathways and glutathione levels in the substantia nigra of mice.
Kang MJ; Gil SJ; Koh HC
Toxicol Lett; 2009 Jul; 188(2):148-52. PubMed ID: 19446248
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
